Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

US FDA Grants New Fast-track Voucher to Partner Therapeutics' Bile Duct Cancer Drug

Private biotech firm Partner Therapeutics said on Wednesday the U.S. Food and Drug Administration ⁠has granted a priority review voucher to its experimental bile duct cancer...

How to Handle Hypoglycemia in Patients Without Diabetes

The tried-and-true Whipple triad stratifies risk.

Ovarian Reserve Testing May Mislead Fertility Assessment

Researchers highlight that age, not ovarian reserve, drives fertility decline, thereby questioning the clinical value of population-level screening strategies.

Nutrition as Therapy: ESPEN Puts Patients First

ESPEN’s new ethics guide reframes medical nutrition as a clinical intervention, urging clinicians to prioritize patient dignity, informed consent, and comfort over futile feeding.

Obesity Subtypes Predict Poor Physical Function in Knee OA

Obesity and low muscle mass and/or cardiometabolic comorbidities impede physical functioning more than obesity alone in individuals with or at risk for knee osteoarthritis.

Promising Revolution Medicines Pancreatic Cancer Drug Has High Rate Of Mostly Manageable Side Effects

An experimental drug from Revolution Medicines that nearly doubled survival time for patients with advanced pancreas cancer in clinical trials comes with a high rate of...

Todays Updates

Accurate and Timely Diagnosis of Endometriosis

Accurate and Timely Diagnosis of Endometriosis

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Many Older Patients Can Ditch Common Thyroid Drug, Study Suggests

Experts call for better guidance on levothyroxine initiation, deprescribing

Todays Updates

Accurate and Timely Diagnosis of Endometriosis

Accurate and Timely Diagnosis of Endometriosis

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Many Older Patients Can Ditch Common Thyroid Drug, Study Suggests

Experts call for better guidance on levothyroxine initiation, deprescribing

Latest News

Private biotech firm Partner Therapeutics said on Wednesday the U.S. Food and Drug Administration ⁠has granted a priority review voucher to its experimental bile duct cancer...

The tried-and-true Whipple triad stratifies risk.

Researchers highlight that age, not ovarian reserve, drives fertility decline, thereby questioning the clinical value of population-level screening strategies.

ESPEN’s new ethics guide reframes medical nutrition as a clinical intervention, urging clinicians to prioritize patient dignity, informed consent, and comfort over futile feeding.

Obesity and low muscle mass and/or cardiometabolic comorbidities impede physical functioning more than obesity alone in individuals with or at risk for knee osteoarthritis.

An experimental drug from Revolution Medicines that nearly doubled survival time for patients with advanced pancreas cancer in clinical trials comes with a high rate of...

News All Time

Encouraging Short-Term Goals for Older Adults With Diabetes

Small steps can build to long-term gains.

Canada Approves Second Generic Version Of Ozempic

The ⁠Canadian health regulator ⁠said on ⁠Friday that ‌it had approved Canada-based Apotex's generic ‌version of semaglutide, making ‌it ‌the second copycat ⁠version of...

Diabetes Before Pregnancy May Affect Kids’ Brain Development

Children of mothers with pregestational diabetes may have an increased risk of developing subsequent neuropsychiatric disorders.

GLP-1 Semaglutide Promising for Alcohol Use Disorder

Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol use disorder.

Constipation Linked to Greater Weight Loss on Semaglutide

Patients on semaglutide who experienced constipation had greater weight loss than those without constipation, and genes could be at play.

GLP-1 Drugs May Modestly Raise Optic Neuropathy Risk in T2D

GLP-1 therapy is linked to a modestly increased risk for nonarteritic anterior ischemic optic neuropathy compared with SGLT2 inhibitors in veterans with type 2 diabetes.

Capecitabine Extends PFS in Oesophagogastric Cancer

Maintenance therapy with capecitabine prolongs progression-free survival in patients with advanced oesophagogastric adenocarcinoma after first-line chemotherapy.

Postop Anorectal Morbidity Notable After Bariatric Surgery

Patients undergoing bariatric surgery experience high rates of new-onset benign anal disorders, with constipation more common after sleeve gastrectomy and diarrhea after gastric bypass.

Too Much, Too Little Exercise Tied to Higher Risk for OA

The fact that upper and lower limits of physical activity are linked to osteoarthritis isn’t surprising, but messaging for patients might take into account the type of physical activity they’re doing.

Early Knee OA Lifestyle Program Fails to Stop Progression

Despite requiring substantial resources, lifestyle programs are unlikely to be successful without including a strong behavioral change component, one commenter noted.

Weight-loss Revolution Sparks New Appetite for Aesthetics Firms

Aesthetic firms are betting that a growing pool of patients experiencing loose skin and facial volume loss from GLP-1 obesity drugs will fuel a new wave of demand, as the...

Gastric Bypass Leads to Diabetes Remission

Laparoscopic one anastomosis gastric bypass achieves sustained diabetes remission in most patients with type 2 diabetes and obesity over 10 years of follow-up.

Biomarkers May Guide Tailored Interventions in Obesity

Nutritional and metabolic biomarkers may aid in the early detection of obesity risk, guide precise interventions, and support tailored diets to improve metabolic health.

Gastric Ring Add-On May Aid Weight Loss After Surgery

A ring-augmented one anastomosis gastric bypass achieves greater weight loss than standard surgery in patients with recurrent weight gain or suboptimal outcomes after sleeve gastrectomy.

Oral Acromegaly Drug Performing Well in First Few Patients

Initial real-world results of patients receiving paltusotine suggest reduced symptoms and good tolerability, while a phase 3 trial finds no interaction with levothyroxine.

Childhood Trauma Tied to Gestational Diabetes Risk

Women with prior adverse childhood experiences may face a higher risk for gestational diabetes, with the risk rising with each additional adverse experience, a meta-analysis of 11 studies shows.

Recommended News For You

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted

Drug-chemo combo increases cancer treatment efficacy

Cancer care crowdfunding increasingly common, but rarely successful

Recommended Articles For You

The New Era of Oncology: Key Updates and Clinical Insights 

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection 

The latest Hematocrit: An Overview of Red Blood Cell Health  

The Surprising Role of Magnesium in Digestion, Sleep and Mental Health  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

2.

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

3.

Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women

4.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

5.

Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.

1.

Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research

2.

AI-Powered Rehabilitation: A Game Changer for Hemophilia Management

3.

Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook

4.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

5.

Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

2.

Navigating the Complexities of Ph Negative ALL - Part VIII

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot